Detalhe da pesquisa
1.
Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study.
J Clin Gastroenterol
; 56(7): 584-591, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049371
2.
Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.
Ann Rheum Dis
; 78(10): 1439-1441, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018960
3.
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials.
Adv Ther
; 40(5): 2439-2456, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995469
4.
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials.
ACR Open Rheumatol
; 5(9): 490-498, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553909
5.
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Rheumatol Ther
; 9(4): 1017-1030, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352313
6.
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials.
RMD Open
; 7(2)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011674
7.
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus.
Arthritis Rheumatol
; 73(3): 472-477, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010188
8.
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies.
Lancet Rheumatol
; 3(10): e715-e723, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287608
9.
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
RMD Open
; 6(1)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209721
10.
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled Trials.
Arthritis Rheumatol
; 71(10): 1660-1669, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31070869
11.
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
Arthritis Rheumatol
; 71(2): 258-270, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225992
12.
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Rheumatol Ther
; 9(4): 1247-1248, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779224
13.
Prevalence, incidence, and distribution of human papillomavirus types in female sex workers in Kenya.
Int J STD AIDS
; 31(2): 109-118, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948341
14.
Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
mBio
; 5(5): e01633-14, 2014 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249280